Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fecal ESBL Resurgence During Antibiotic Treatment

NCT03206879 is registered in ClinicalTrials.gov with University Hospital, Akershus as lead sponsor.

NCT NCT03206879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03206879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fecal ESBL Resurgence During Antibiotic Treatment
Lead sponsor
University Hospital, Akershus
Phase
Observational
Overall status
Terminated
Start date
November 30, 2016
Completion date
December 31, 2018
Enrollment
50 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic drug resistance